Letter from Redox CEO

June 14, 2023
Luke Bonney Co-Founder & CEO

This week we had to say goodbye to Redoxers we love, reducing the size of our team by 8%. Each of these Redoxers is talented and hardworking. These layoffs are not a reflection of their performance, but instead represent a tough but necessary decision the leadership team and I made to focus on our core business priorities: serving our customers and advancing our purpose to make healthcare data useful.

When we looked closely at what we need to deliver for our customers and partners in 2023 and 2024, we saw an opportunity to deliver on those needs with a leaner, more focused team. This decision is about Redox’s sustainable future.

With these hard choices comes opportunity. We’re still growing quickly, still bringing powerful new innovations to market. Our volume of live connections and total transactions we process continues to grow. In partnership with our customers we continue to drive the impact we all believe in as we seek to improve healthcare for everyone.

I would personally recommend every Redoxer who is leaving us. They are deeply skilled and knowledgeable about the inner workings of the health tech industry and they each have helped make Redox the company it is today.

If you are hiring and would like to consider one of these incredible teammates, please reach out to Thao Diep ([email protected]) from our talent acquisition team ​​and we will share your openings with our Alumni group. Ideally, these folks can stay within the industry to take advantage of their time at Redox and continue to drive impact with our customers, partners, and healthcare delivery organizations.

We’ve always known that solving the problem we’re tackling doesn’t happen overnight. We’re committed to making the world’s healthcare data useful not just today, but into the future. Our decision this week hurts, but positions us to drive the change we all want to see.

Stay in the know! Subscribe to our newsletter.